Cargando…
The role of third-line chemotherapy in recurrent or metastatic gastric cancer: A cohort study with propensity score matching analysis
In recurrent or metastatic gastric cancer, second-line chemotherapy is generally recommended in current guidelines. Although third-line therapy is often performed in daily practice in some countries, there are only a few reports about its benefits. A retrospective review was conducted on 682 patient...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181587/ https://www.ncbi.nlm.nih.gov/pubmed/30278571 http://dx.doi.org/10.1097/MD.0000000000012588 |